Favorable longitudinal outcome in a patient with Parry-Romberg syndrome

Acta Neurologica Scandinavica

Volumn 112, Issue 3, 2005, Pages 192-193

  Waters, Michael F ^a,b   Bhidayasiri, R ^a   Shields, W D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE;

ANTICONVULSANT THERAPY; CASE REPORT; CHILD; CLINICAL FEATURE; CONVULSION; FACE SURGERY; FEMALE; HEMIFACIAL ATROPHY; HUMAN; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADOLESCENT; BRAIN; CHILD; CHILD, PRESCHOOL; FACIAL HEMIATROPHY; FEMALE; HUMANS; TIME FACTORS; TREATMENT OUTCOME;

EID: 23844500347     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2005.00452.x     Document Type: Note

References (4)

1. WOLF SM, VERITY MA. Neurological complications of progressive facial hemiatrophy. J Neurol Neurosurg Psychiatry 1974;37:997-1004.
2. LEHMAN TJ. The Parry Romberg syndrome of progressive facial hemiatrophy and linear scleroderma en coup de sabre. Mistaken diagnosis or overlapping conditions? J Rheumatol 1992;19:844-5.
3. MOKO SB, MISTRY Y, BLANDIN DE CHALAIN TM. Parry-Romberg syndrome: intracranial MRI appearances. J Craniomaxillofac Surg 2003;31:321-4.
4. SHAH JR, JUHASZ C, KUPSKY WJ et al. Rasmussen encephalitis associated with Parry-Romberg syndrome. Neurology 2003;61:395-7.